Actively Recruiting
Light Therapy in End Stage Kidney Disease
Led by University of Pennsylvania · Updated on 2026-03-27
60
Participants Needed
1
Research Sites
25 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.
CONDITIONS
Official Title
Light Therapy in End Stage Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent prior to starting any study procedures
- Male or female participants aged 18 years or older
- Diagnosis of end stage kidney disease receiving hemodialysis three times per week for at least one month
- Fatigue Severity Scale (FSS) score greater than 9 at enrollment
- Access to a home refrigerator for storing salivary cortisol samples
You will not qualify if you...
- Eye disorders including cataracts, glaucoma, or retinal disorders such as macular degeneration
- Photosensitivity conditions like epilepsy
- Currently hospitalized or acutely ill
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
L
Lea Ann Matura, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here